HOME >> BIOLOGY >> NEWS
In a tiny squid, bacterial toxin governs organ development

MADISON - In a tiny Pacific Ocean squid, a toxic molecule that causes whooping cough and gonorrhea in humans has been found to be a critical catalyst for organ development.

The toxin, produced by different types of bacteria in different hosts, is known as tracheal cytotoxin. And the astonishing discovery that it can be either good or bad - depending on its biological context - promises to rattle long-held perceptions of microbes and their role as pathogens.

The new work, funded by the National Institutes of Health, was reported this week (Nov. 12) in the journal Science.

That the same toxic molecule produced by different bacteria in different host animals plays such disparate roles - disease and massive tissue damage on the one hand, and critical organ development on the other - may force biologists to rethink the relationship between the world's many microorganisms and their host plants and animals, according to Margaret McFall-Ngai, a University of Wisconsin-Madison professor of medical microbiology and the corresponding author of the Science paper.

"It is all context dependent," says McFall-Ngai. "It has to be that we have mechanisms to use these molecules in different ways. Until now, molecules of a virulent nature have not been recognized as having essential roles in development."

In the diminutive Hawaiian bobtail squid, the toxin was found to spur the development of a structure, a light-producing organ that acts as a sort of "Klingon cloaking device," mimicking starlight to confuse hungry predators lurking in the depths. In humans, the same toxic molecule, produced by different species of bacteria, causes massive tissue damage in the lungs in the case of whooping cough, and in the fallopian tubes in the case of gonorrhea.

When the squid are born, they are about half the size of a grain of rice, and they must acquire the toxin-producing bacteria from their oc
'"/>

Contact: Margaret McFall-Ngai
mjmcfallngai@wisc.edu
608-262-2393
University of Wisconsin-Madison
11-Nov-2004


Page: 1 2 3

Related biology news :

1. A new plant-bacterial symbiotic mechanism promising
2. UCF professor finds bacterial pathogen may be key to understanding cancer development
3. Researchers discover acquired DNA key to certain bacterial infection
4. Hot on the TRAIL of controlling inflammation in bacterial meningitis
5. A new plant-bacterial symbiotic mechanism promising for crop applications
6. Researchers develop way to calculate speed of bacterial sex
7. Gallium: A new antibacterial agent?
8. New antibacterials being developed to tackle MRSA superbug
9. The pull of bacterial chromosome segregation
10. Green plants share bacterial toxin
11. ASU researchers test antibacterial effects of healing clays

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... 28, 2017 Dr. Chris Yu ... corporation Anpac Bio-Medical Science Company , announced ... record, processing and reporting over 40,000 cases worldwide ... (CDA) liquid biopsy tests. Described ... Summit publications, Anpac Bio,s CDA medical devices and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for Parkinson’s ... study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation ... produce more neural cells. , Strategies involving transplantation of these cells into ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. (NASDAQ: ... solutions for the detection of foodborne pathogens,  today announced that ... & Company Spring 2017 Convention on March 29 at 9:50am ... Marriott Marquis. About Roka Bioscience ... Roka Bioscience ...
Breaking Biology Technology:
Cached News: